合成橡胶输液帮浦市场规模、份额、成长分析、按产品、按应用、按最终用途、按地区 - 产业预测，2024-2031 年

2022年，全球合成橡胶输液帮浦市场规模将达到6.38亿美元，从2023年的6.8457亿美元成长到2031年的12.0287亿美元，预计在预测期内（2024年~2031年）成长。 7.30%。

由于多种因素的综合作用凸显了对先进医疗输送系统的需求不断增长，全球合成橡胶输液帮浦市场预计将显着成长。整形外科手术和手术数量的增加、对紧凑型一次性门诊合成橡胶输液帮浦的需求不断增长以及技术的快速进步正在促进市场扩张。值得注意的是，慢性病，特别是糖尿病的盛行率正在增加。国际糖尿病联盟最近的统计数据显示，糖尿病患者数量惊人增加，预测到 2030 年，大约有 6.43 亿成年人将受到这种疾病的影响。据世界卫生组织 (WHO) 称，此类慢性疾病每年导致 4,100 万人死亡，凸显了有效管理解决方案的迫切需求。此外，骨髓炎等疾病呈上升趋势，在美国每年报告约 50,000 例病例，特别是在患有糖尿病和周围血管疾病等併发症的人群中。慢性疾病负担的迅速增加正在推动对安全有效的静脉给药的需求，从而推动合成橡胶输液帮浦市场的发展。随着医疗保健系统越来越重视改善患者治疗效果和采用创新技术，美国合成橡胶输液帮浦市场预计将在未来的预测期内实现永续年增长率。这一趋势反映了医疗设备业相关人员加强患者照护并满足医疗保健提供者不断变化的需求的重大机会。

目录

介绍

• 研究目的
• 定义
• 市场范围

调查方法

• 资讯采购
• 次要/一级资讯来源
• 市场规模预测
• 市场假设与限制

执行摘要

• 市场概况展望
• 供需趋势分析
• 按细分市场的机会分析

市场动态及展望

• 市场动态
  • 促进因素
  • 机会
  • 抑制因素
  • 任务
• 波特的分析

主要市场考察

• 技术分析
• 价值链分析
• 市场生态系统
• 案例研究分析
• 监管环境
• 创新矩阵
• 重点投资分析
• 关键成功因素
• 竞争程度

合成橡胶输液帮浦市场：副产品

• 市场概况
• 连续速度合成橡胶输液泵
• 变速合成橡胶输液泵

合成橡胶输液帮浦市场：依应用分类

• 市场概况
• 疼痛管理
• 化疗
• 抗生素/抗病毒治疗
• 其他的

合成橡胶输液帮浦市场：依最终用途分类

• 市场概况
• 医院
• 门诊手术中心
• 其他的

各地区合成橡胶输液帮浦市场规模

• 市场概况
• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲国家地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 其他亚太地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地区
• 中东和非洲 (MEA)
  • 海湾合作委员会国家
  • 南非
  • 其他中东/非洲地区

竞争格局

• 前5名企业对比
• 主要企业市场定位（2023年）
• 主要市场参与者所采取的策略
• 近期市集活动
• 主要企业市场占有率（2023年）

主要企业简介

• Baxter（US）
• Fresenius Kabi AG（Germany）
• B. Braun SE（Germany）
• Ambu A/S（Denmark）
• NIPRO（Japan）
• Terumo Corporation（Japan）
• AVNS（US）
• Vygon Group（France）
• Smiths Group plc（UK）
• ICU Medical, Inc.（US）
• Pajunk GmbH（Germany）
• Woo Young Medical Co., Ltd.（South Korea）
• Sapphire Medical（Israel）
• Ace Medical Co., Ltd.（South Korea）
• Eitan Medical（Israel）
• Zyno Medical（US）
• Epic Medical（Singapore）
• Nipro Corporation（Japan）
• Daiken Medical Co., Ltd.（Japan）
• Coopdech（Japan）
• Westmed, Inc.（US）
• Flowonix Medical Inc.（US）

Global Elastomeric Infusion Pumps Market size was valued at USD 638 million in 2022 and is poised to grow from USD 684.57 million in 2023 to USD 1202.87 million by 2031, growing at a CAGR of 7.30% during the forecast period (2024-2031).

The global elastomeric infusion pump market is poised for substantial growth, driven by a confluence of factors that highlight the increasing need for advanced medical delivery systems. A rising number of orthopedic procedures and surgeries, heightened demand for compact, disposable ambulatory elastomeric infusion pumps, and rapid technological advancements are all contributing to market expansion. Notably, the growing prevalence of chronic diseases, particularly diabetes, serves as a primary growth catalyst. Recent statistics from the International Diabetes Federation illustrate the alarming rise in diabetes cases, with projections indicating approximately 643 million adults will be affected by the condition by 2030. Such chronic ailments account for 41 million deaths annually, according to the World Health Organization, emphasizing an urgent need for effective management solutions. Additionally, conditions like osteomyelitis, which reports around 50,000 cases annually in the US, are on the rise, notably among demographics with existing comorbidities such as diabetes and peripheral vascular disease. This burgeoning burden of chronic diseases underscores the critical demand for safe and effective medication delivery through intravenous routes, consequently propelling the elastomeric infusion pump market. As healthcare systems increasingly prioritize improved patient outcomes and the adoption of innovative technologies, the US elastomeric infusion pumps market is expected to achieve a sustainable compound annual growth rate (CAGR) in the forecast period ahead. This trend reflects a significant opportunity for stakeholders in the medical device industry to enhance patient care and address the evolving needs of healthcare providers.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Elastomeric Infusion Pumps market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Elastomeric Infusion Pumps Market Segmental Analysis

Global Elastomeric Infusion Pumps Market is segmented by Product, Application, End Use, and region. Based on Product, the market is segmented into Continuous Rate Elastomeric Infusion Pumps, and Variable Rate Elastomeric Infusion Pumps. Based on function, the market is segmented into Pain Management, Chemotherapy, Antibiotic/Antiviral Therapy, and Others. Based on End Use, the market is segmented into Hospitals, Ambulatory Surgical Centers, and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.

Driver of the Global Elastomeric Infusion Pumps Market

The escalating prevalence of chronic diseases, including diabetes, cancer, and cardiovascular disorders, is a pivotal market driver for the Global Elastomeric Infusion Pumps market. As healthcare systems prioritize efficient and patient-friendly treatment modalities, elastomeric infusion pumps emerge as a preferred choice due to their ability to deliver medications consistently over extended periods. These devices offer several advantages, such as portability, ease of use, and reduced risk of infection, making them ideal for outpatient settings. Consequently, the growing demand for effective long-term medication management solutions significantly boosts the market's growth potential, highlighting the critical role of elastomeric infusion pumps in modern healthcare.

Restraints in the Global Elastomeric Infusion Pumps Market

The Global Elastomeric Infusion Pumps market is significantly restrained by the growing competition from alternative drug delivery systems, particularly electronic infusion pumps and implantable pumps. These alternatives not only incorporate advanced technological features but also provide more precise drug delivery methods, appealing to healthcare providers and patients alike. As these innovative systems continue to evolve, they pose substantial challenges to the adoption and market penetration of elastomeric infusion pumps. This competitive landscape compels manufacturers to enhance the functionality and efficiency of elastomeric devices or risk becoming obsolete, ultimately hindering market growth in the burgeoning healthcare sector.

Market Trends of the Global Elastomeric Infusion Pumps Market

The global elastomeric infusion pumps market is experiencing a significant upward trend, primarily fueled by the increasing demand for home healthcare and ambulatory care solutions. This shift is driven by an aging population seeking cost-effective treatment options, coupled with advancements in medical technology that enhance the usability of these devices. The portability and user-friendly design of elastomeric infusion pumps allow patients to administer continuous medication infusions in the comfort of their own homes, thereby improving patient satisfaction and outcomes. As healthcare facilities face mounting pressures, the rising adoption of these pumps is set to redefine patient care dynamics and reshape market strategies.

Table of Contents

Introduction

• Objectives of the Study
• Definitions
• Market Scope

Research Methodology

• Information Procurement
• Secondary & Primary Data Sources
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Market Overview Outlook
• Supply Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Dynamics
  • Drivers
  • Opportunities
  • Restraints
  • Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of Substitute Products
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Technology Analysis
• Value Chain Analysis
• Ecosystem of the Market
• Case study Analysis
• Regulatory Landscape
• Innovation Matrix
• Top Investment Analysis
• Key Success Factor
• Degree of Competition

Elastomeric Infusion Pumps Market by Product

• Market Overview
• Continuous Rate Elastomeric Infusion Pumps
• Variable Rate Elastomeric Infusion Pumps

Elastomeric Infusion Pumps Market by Application

• Market Overview
• Pain Management
• Chemotherapy
• Antibiotic/Antiviral Therapy
• Others

Elastomeric Infusion Pumps Market by End Use

• Market Overview
• Hospitals
• Ambulatory Surgical Centers
• Others

Elastomeric Infusion Pumps Market Size by Region

• Market Overview
• North America
  • USA
  • Canada
• Europe
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America
  • Brazil
  • Rest of Latin America
• Middle East & Africa (MEA)
  • GCC Countries
  • South Africa
  • Rest of MEA

Competitive Landscape

• Top 5 Player Comparison
• Market Positioning of Key Players, 2023
• Strategies Adopted by Key Market Players
• Recent Activities in the Market
• Key Companies Market Share (%), 2023

Key Company Profiles

• Baxter (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fresenius Kabi AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• B. Braun SE (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ambu A/S (Denmark)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• NIPRO (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Terumo Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AVNS (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Vygon Group (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Smiths Group plc (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ICU Medical, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pajunk GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Woo Young Medical Co., Ltd. (South Korea)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sapphire Medical (Israel)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ace Medical Co., Ltd. (South Korea)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eitan Medical (Israel)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Zyno Medical (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Epic Medical (Singapore)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nipro Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Daiken Medical Co., Ltd. (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Coopdech (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Westmed, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Flowonix Medical Inc. (US
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments